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Abstract. 
 
Nuclear domain 10 (ND10), also referred to 
as nuclear bodies, are discrete interchromosomal accu-
mulations of several proteins including promyelocytic 
leukemia protein (PML) and Sp100. In this study, we 
investigated the mechanism of ND10 assembly by iden-
tifying proteins that are essential for this process using 
cells lines that lack individual ND10-associated pro-
teins. We identiﬁed the adapter protein Daxx and BML, 
the RecQ helicase missing in Bloom syndrome, as new 
ND10-associated proteins. PML, but not BLM or 
Sp100, was found to be responsible for the proper local-
ization of all other ND10-associated proteins since they 
 
are dispersed in PML
 
2
 
/
 
2
 
 cells. Introducing PML into 
this cell line by transient expression or fusion with 
PML-producing cells recruited ND10-associated pro-
teins into de novo formed ND10 attesting to PMLs es-
sential nature in ND10 formation. In the absence of 
PML, Daxx is highly enriched in condensed chromatin. 
Its recruitment to ND10 from condensed chromatin re-
quires a small ubiquitin-related modiﬁer (SUMO-1) 
modiﬁcation of PML and reﬂects the interaction be-
tween the COOH-terminal domain of Daxx and PML. 
The segregation of Daxx from condensed chromatin in 
the absence of PML to ND10 by increased accumula-
tion of SUMO-1–modiﬁed PML suggests the presence 
of a variable equilibrium between these two nuclear 
sites. Our ﬁndings identify the basic requirements for 
ND10 formation and suggest a dynamic mechanism for 
protein recruitment to these nuclear domains con-
trolled by the SUMO-1 modiﬁcation state of PML.
Key words: nuclear structure • nuclear proteins • pro-
tein interaction • supramolecular regulation • knock-
out cells
 
S
 
PECIFIC
 
 nuclear domains, ND10
 
1
 
 (also referred to as
PML nuclear bodies or promyelocytic oncogenic
domain), but more specifically their constituent pro-
teins have been intensively investigated, following the
findings that some ND10-associated proteins are con-
nected to certain disease processes. One of the proteins
consistently present in ND10 is Sp100, autoantibodies to
which are prevalent in primary billiary cirrhosis (Szostecki
et al., 1990). Another protein in ND10 is the promyelo-
cytic leukemia protein (PML), which is fused to the reti-
noic acid receptor 
 
a
 
 in acute promyelocytic leukemia
(APL) (deThe et al., 1990; Goddard et al., 1991; Kakizuka
et al., 1991; Pandolfi et al., 1991). The presence of wild-
type PML in ND10 and the dispersion of this structure in
APL suggested the involvement of these domains in the
differentiation of promyelocytes (Dyck et al., 1994; Weis
et al., 1994). Also, PML has recently become the center of
attention in other contexts. It was identified as a tumor
suppressor protein (Mu et al., 1994), involved in apoptosis
(Quignon et al., 1998; Wang et al., 1998), a regulator of
MHC expression (Zheng et al., 1998) and, together with
Sp100, to be upregulated by interferon (Lavau et al., 1995;
Grotzinger et al., 1996). Disparate information about
ND10 as a nuclear structure is surreptitiously accumulat-
ing from several investigative directions. A concentrated
approach to solve the question of how such a prominent
nuclear domain is formed and maintained has been lack-
ing. We focus here on how ND10 are assembled and how
its formation and maintenance are controlled within the
 
conceptual background that defines ND10 as a poten-
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1. 
 
Abbreviations used in this paper:
 
 APC, acute promyelocytic leukemia;
BSF, human Bloom syndrome–derived primary fibroblasts; Daxx, Fas
death domain–associated protein; HF, human primary fibroblasts; MPEF,
embryonic primary mouse fibroblasts; ND10, nuclear domain 10; NGP,
human neuroblastoma cells; PML, promyelocytic leukemia protein;
PML
 
2
 
/
 
2
 
 MPEF, SV40 large T-antigen transformed cells derived from
embryos of PML
 
2
 
/
 
2
 
 knockout mouse; Sp100, autoantigen in primary bil-
liary cirrhosis; SUMO-1, small ubiquitin-related modifier. 
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tial  nuclear depot where certain proteins are regulated
through recruitment and release.
ND10 are structurally defined by the immunohisto-
chemical localization of certain proteins at specific punc-
tate nuclear sites. New ND10-associated proteins are,
therefore, often found accidentally when such patterns are
discovered while working on a given protein in other con-
texts. Such was the case with two proteins that will feature
in the present attempt to evaluate ND10 structure. One of
them, Daxx, has been identified as a protein that binds
with its COOH-terminal end to the Fas death domain
(Yang et al., 1997), the centromeric protein CENP-C
(Pluta et al., 1998), the transcription factor Pax3 (Hollen-
bach et al., 1999), and DNA methyltransferase I (Michael-
son et al., 1999). None of these proteins are located pre-
dominantly at ND10. Daxx also has been found to interact
with the steroidogenic acute regulatory protein gene pro-
moter DNA sequence (Kiriakidou et al., 1997), and anti-
bodies against Daxx showed a nuclear distribution like
ND10. Therefore, it was further investigated in the context
of ND10 structure. Similar to Daxx, BLM, the RecQ heli-
case missing in the Bloom syndrome patients, had a punc-
tate distribution in most cells (Neff et al., 1999), which in
the course of this investigation proved to be ND10. There-
fore, BLM
 
2
 
/
 
2
 
 fibroblasts could be used to test what ef-
fect lack of BLM has on the structure of ND10.
The stability, function, and localization of proteins can
be changed by posttranscriptional modification. At least
four ND10 proteins, Sp100, PML, CBP, and pRB, are
phosphoproteins, and PML and Sp100 are covalently mod-
ified by the small ubiquitin-related modifier (SUMO-1)
(Sternsdorf et al., 1997; Kamitani et al., 1998b; Muller et al.,
1998). SUMO-1 modification of PML has been suggested
to target this protein to ND10 (Muller et al., 1998), and re-
moval of sites for SUMO-1 modification from PML seems
to prevent PML from accumulating in ND10 (Kamitani
et al., 1998a). In contrast, such a modification did not influ-
ence the localization pattern for Sp100 (Sternsdorf et al.,
1997). Therefore, modification of PML as a determinant
of its interaction with other proteins suggests itself as a po-
tential control mechanism in the accumulation of proteins
at ND10. The effect of SUMO-1 modification or the lack
of such modification may be central to the structural integ-
rity of ND10 and needs to be evaluated.
A remarkable feature of ND10 is the deposition of
DNA viruses, such as herpes simplex virus type 1, cyto-
megalovirus, adenovirus 5, and SV40, at ND10 and that their
transcription and replication begins associated with these
sites (Ishov and Maul, 1996; Maul et al., 1996; Ishov et al.,
1997). Except for SV40, these viruses express proteins that
modify ND10. Specifically, ICP0 of herpes simplex virus
type 1 accumulates in ND10 and induces degradation of
ND10-associated proteins (Maul et al., 1993; Everett and
Maul, 1994; Maul and Everett, 1994; Everett et al., 1998,
1999; Chelbi-Alix and de The, 1999). The degradation of
PML involves desumofication followed by hydrolysis
through the ubiquitin/proteosome pathway (Everett et al.,
1998, 1999). This finding implicated desumofication and/or
hydrolysis of PML in the destruction of ND10, although
the advantage to the virus is as yet not apparent.
ND10 are modified by other effectors of nuclear func-
tions. Stress in the form of heat shock or heavy metal ex-
 
posure results in dispersion of ND10-associated proteins
(Maul et al., 1995). Increases in the number and size of
ND10 have been reported to be due to the interferon-
induced upregulation of PML and Sp100 (Lavau et al.,
1995; Grotzinger et al., 1996). Also, the earliest observed
changes in ND10 were the size variations associated with
hormonal changes in the uterine endometrium and the
mammary epithelial cells (Padykula et al., 1981; Fitzgerald
and Padykula, 1983). Common to all the agents that in-
duce modifications in ND10 are their global effects on the
nuclear metabolism, although the signaling pathway that
affects the changes at ND10 is wholly unexplored and can
only be approached after we have knowledge on the re-
cruitment and release mechanisms at this nuclear site.
ND10s are dispersed upon viral infection and in APL
and are reassembled upon treatment of this disease by ret-
inoic acid and arsenic (As
 
2
 
O
 
3
 
). This strongly suggests that
this nuclear structure is important for a number of patho-
logical processes. Therefore, investigating the assembly
mechanism is an essential step toward understanding
ND10 function in disease processes as well as in normal
nuclear activities. Because the mechanism of ND10 assem-
bly is likely to involve protein–protein interactions, we
carried out studies to identify proteins that are essential
for the formation of these domains. During the course of
this study, we found the following: (1) PML, but not Sp100
nor the new ND10 component BLM, is essential for ND10
assembly; (2) the recently characterized Daxx (Kiriakidou
et al., 1997; Yang et al., 1997; Pluta et al., 1998; Hollenbach
et al., 1999; Michaelson et al., 1999) is a new ND10-associ-
ated protein and interacts with PML; (3) this interaction is
necessary to recruit Daxx from heterochromatin to ND10;
and (4) this recruitment is controlled by SUMO-1 modifi-
cation of PML. Taken together, these results provide us
with the basics of ND10 formation and suggest a mecha-
nism for its dynamic control.
 
Materials and Methods
 
Cells and Growth Conditions
 
HEp-2 carcinoma human primary fibroblasts (HF) have been previously
described (Ishov et al., 1997). Fibroblasts from Bloom syndrome patient
(GM01492F) were obtained from the Coriell Institute for Medical Re-
search; mouse primary embryonic fibroblasts (MPEF) and PML
 
2
 
/
 
2
 
mouse primary embryonic fibroblasts (PML
 
2
 
/
 
2
 
 MPEF; Wang et al.,
1998), N-myc-amplified neuroblastoma NGP cells (Zehnbauer et al., 1988),
were maintained in DME supplemented with 10% FCS and antibiotics.
Human embryonic NT2 cells and the retinoic acid–differentiated NT2 cells
were provided by V. Lee (University of Pennsylvania) (Kleppner et al.,
1995). All cells were grown at 37
 
8
 
C in a humidified 5% CO
 
2 
 
atmosphere.
For immunohistochemical staining, cells were grown on round coverslips
in 24-well plates (Corning Glass, Inc.) until 
 
z
 
80% confluent before fixa-
tion. For cell fusion experiments, both cell types were plated on glass cov-
erslips at a 1:1 ratio. The following day, they were treated with prewarmed
50% PEG-6000 (Serva Co.) for 2 min and washed three times with com-
plete culture medium. Immunostaining was performed 16 h after fusion.
Unfused cells in the PEG-6000–treated cells and unmixed fused cells were
used as negative controls. During microscopic analysis, DNA staining (0.5
 
m
 
g/ml Hoechst 33258; American Hoechst) was used to identify the nuclei
of mouse and human cells.
 
Antibodies
 
ND10 were visualized using the following antibodies: mAb 138 labels
NDP55 (Ascoli and Maul, 1991), whereas mAb 5E10 reacts with PML 
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(Stuurman et al., 1992). Isotype-matched mAbs of unrelated specificity
were used as controls. Polyclonal rabbit antiserum against PML and rabbit
antibodies against Sp100 were obtained from Dr. J. Frey (Korioth et al.,
1996). A human antiserum specific for Sp100 from patients with primary
billiary cirrhosis was found positive for mouse ND10. Human serum 602
recognized the centromeres in immunohistochemistry and the centro-
meric recombinant protein CENP-C in Western blots (Jarzabek-Chorzel-
ska et al., 1990). Rabbit antibodies against human Daxx were produced
using recombinant RGS-His-tagged human Daxx purified on NTX resin
(Qiagen). Antibodies against RGS-HIS were purchased from Qiagen. A
different antibody against hDaxx was produced in mouse against the
hDaxx COOH-terminal 480–740 amino acid fragment. In addition, a rab-
bit anti–Daxx antibody was purchased from Santa Cruz Biotechnology,
Inc. Antibodies against SUMO-1 were obtained from Dr. P. Freemont
(I.C.R.F. London) (Boddy et al., 1996). Anti-CBP, antibodies were pur-
chased from Santa Cruz Biotechnology, Inc., and those against RGS-His
from Qiagen (Valencia, CA). Rabbit anti-BLM has been described (Neff
et al., 1999).
 
Immunolocalization of Proteins
 
2 d after plating on round glass coverslips, cells were fixed at room tem-
perature for 15 min with freshly prepared 1% paraformaldehyde in PBS
and treated as previously described (Ishov and Maul, 1996). Cells were an-
alyzed using a Leica confocal laser scanning microscope. Leica image en-
hancement software was used to balance signal strength and eightfold
scanning was used to separate signal from noise. Because of the variability
among cells in any given culture, the most prevalent cells were photo-
graphed and are presented as small groups of nuclei or single nuclear im-
ages at high magnification.
 
Yeast Two-Hybrid Protein Interaction Assay
 
The interaction between Daxx and PML or Sp100 was measured in a yeast
two-hybrid assay using 
 
b
 
-galactosidase activity as a reporter of protein–
protein interaction. Sp100 and PML were cloned in the pAS1 vector that
contains the TRP1 gene (Durfee et al., 1993), so that these proteins are
fused to GAL4-DBD (a gift from R. Evans, Salk Institut). The pAS1-
PML
 
D 
 
coil deletion mutant was generated by digestion of pAS1-PML
with endonuclease Bss
 
 
 
HII and self-ligation, which resulted in a deletion
of 214–329 amino acids of the PML protein. hDaxx cDNA and the respec-
tive mutants were produced by PCR using the high fidelity Vent poly-
merase (New England Biolabs) and pQE-30 hDaxx (Kiriakidou et al.,
1997) as a template and cloned into the BamHI site downstream of NLS-
VP16 driven by the ADH promoter into pVP16 (Vojtek et al., 1993),
which carries the LEU2 gene. pSD5 (a gift from S. Berger, The Wistar In-
stitute) containing the HIS2 gene and GAL4 binding site upstream of the
bacterial 
 
lacZ 
 
gene was used as a reporter plasmid. Plasmids were trans-
fected into the 
 
trp1
 
 derivative of yeast strain PSY316 (MAT
 
a
 
 
 
his 
 
3-200 
 
leu
 
2-3, 112 
 
lys
 
 2 
 
ura
 
 3-53) (Candau et al., 1996). 
 
b
 
-galactosidase activity was
assessed and normalized to protein concentration as described (Rose et
al., 1998). The data represent results of three independent experiments.
 
Probes and Expression Plasmids
 
To analyze the intranuclear distribution of various Daxx mutants, we first
constructed a pET plasmid, encoding GFP with a nuclear localization sig-
nal from SV40 large T-antigen (amino acid PKKKRKV). Two synthetic
oligonucleotides (5
 
9
 
-AATTCTCCTAAGAAGAAGCGTAAGG-3
 
9
 
 and
5
 
9
 
-TCGACCTTACGCTTCTTCTTAGGAG-3
 
9
 
) were annealed and in-
serted into the COOH-terminal end of the GFP open reading frame be-
tween the EcoRI and SalI sites on pEGFP-C1 (CLONTECH Laborato-
ries). Different deletion mutants of hDaxx were constructed by subcloning
into BamHI cut pET vector. The respective fragments of BamHI cut PCR
products were amplified with the sense primer 5
 
9
 
-CACACGGATCCGCCAC-
CGCTAACAGC-3
 
9
 
 and the antisense primers: 5
 
9
 
-GTGGTGGATC-
CCTCCTCTGATTGCTTCCTGG-3
 
9
 
 for Daxx 1–595 amino acids; 5
 
9
 
-
GTGGTGGATCCATCAGAGTCTGAGAGCACGATG-3
 
9
 
 for Daxx
1–740 amino acids; or BglII-BamHI cut PCR fragment amplified with 5
 
9
 
-
CACACAGATCTGATTCTGGTCCCCCCTGC-3
 
9 
 
as the sense and
antisense primers 5
 
9
 
-GTGGTGGATCCATCAGAGTCTGAGAGCAC-
GATG-3
 
9
 
 for Daxx 624–740 amino acids using high fidelity Vent poly-
merase (New England Biolabs) and pQE-30hDaxx (Kiriakidou et al.,
1997) as a template for the Daxx gene. All constructs were verified by se-
quencing. Plasmids PML-K65,160,490R (referred to here as PML
 
D
 
-
SUMO), PML-K65R, and PML-K65,160R (Kamitani et al., 1998a), based
 
on the pcDNA3 plasmid (Invitrogen), expresses RGS-His-fused PML mu-
tants with corresponding lysines substituted by arginines. Transient trans-
fections were carried out using the DOSPER reagent (Boehringer) ac-
cording to the manufacturer’s recommendations.
 
Results
 
Identification of the Protein Essential for the 
Maintenance of ND10 by Using Cell Lines Lacking 
Specific ND10-associated Proteins
 
To address the question, which proteins are essential for
the formation or maintenance of ND10, we identified cell
lines that do not express certain ND10-associated proteins.
The first cell line identified came from the observation
that the BLM protein, a member of the DExH box con-
taining DNA helicases, was located in discrete nuclear do-
mains in most cells (Neff et al., 1999). Immunostaining of
BML
 
2
 
/
 
2
 
 fibroblasts derived from BLM syndrome pa-
tients did not reveal any discrete domain staining, confirm-
ing specificity of BML localization at such sites in normal
cells. These patients are homozygous for the mutation in
the BLM gene, which leads to the early truncation of the
BLM helicase. Double labeling of primary human fibro-
blasts with antibodies against PML, a constitutive ND10-
associated protein, and antibodies against BLM showed
that the two antibodies labeled ND10 (Fig. 1, A–C). To
determine whether the absence of BLM helicase affects
ND10, BML
 
2
 
/
 
2
 
 fibroblasts were double labeled with an-
tibodies against several ND10-associated proteins (PML,
Sp100, SUMO-1, and CBP). All were detected in ND10
(shown for PML in Fig. 1, D–F). Thus, BLM helicase is not
essential for the formation of ND10.
In previous studies, we found that nuclei of most brain
cells do not contain Sp100 accumulations (Cho et al.,
1998). Therefore, we checked for Sp100 expression in hu-
man NT2 embryocarcinoma cells, which can be induced to
differentiate into nerve-like cells by retinoic acid (Dyck et al.,
1995). Using HEp-2 cells as a control, we tested by West-
ern blot analysis for the presence of Sp100 and PML in
NT2 cells. Since Sp100, as well as PML, have interferon re-
sponse elements in their promoter regions (Grotzinger et al.,
1996), we stimulated the cells for 24 h with interferon 
 
a
 
 to
upregulate a potentially undetectable level of expression.
Both cell lines contained PML (Fig. 1 J, lanes 5 and 7), al-
though the amount of PML was higher in the HEp-2 cells.
Interferon treatment dramatically increased the amount of
PML (compare lanes 5 and 6 with 7 and 8). The unspecific
band marked by an asterisk indicates equal loading. No
Sp100 was found in NT2 cells even upon interferon upreg-
ulation (lanes 1 and 2), whereas in HEp2 cells interferon
treatment resulted in a massive enhancement of the Sp100
signal (lanes 3 and 4). The results of Western blot analysis
were confirmed by immunostaining with two different
anti–Sp100 antibodies of human and rabbit origin. No
Sp100 accumulations were seen in NT2 cells with or with-
out interferon activation (shown for rabbit Sp100 antibod-
ies in Fig. 1, G–I). However, most NT2 cells contained
ND10 as judged by the presence of PML at specific sites.
Analysis using the entire panel of ND10-specific antibod-
ies revealed the presence of all corresponding antigens at
the PML-positive sites. The negative Sp100 phenotype was
also retained after differentiation induced by retinoic acid 
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treatment and in NGP neuroblastoma cells (data not
shown). Thus, we concluded that Sp100 was absent in NT2
cells and, that the presence of Sp100 was not essential for
the maintenance of ND10.
The question whether PML is important for ND10 as-
sembly and maintenance was tested in PML
 
2
 
/
 
2
 
 MPEF
cells. To obtain a reasonable assurance that ND10 are
present or absent in PML
 
2
 
/
 
2
 
 MPEF cells, we needed a
Figure 1. The new component of ND10, BLM helicase, as
well as Sp100 are not necessary for ND10 maintenance. Con-
focal micrographs of various cells are presented with the la-
beled proteins in the upper corners. The cell type is indicated
at the lower part of the image. (A–C) HF double labeled for
BLM protein (A) and PML (B); the merged image shows
that both proteins colocalize (C). (D–F) Bloom syndrome fi-
broblasts (BF) double labeled for BLM (D) and PML (E);
there is no ND10 labeling with the BLM antibodies (F). (G–I)
NT2 cells double labeled for Sp100 (G) and PML (H); there
is no ND10 labeling for Sp100 (I). (J) Western blot analysis to
determine the presence of Sp100 (lanes 1–4) and PML (lanes
5–8) in NT2 (lanes 1, 2, 5, and 6) and HEp-2 cells (lanes 3, 4,
7, and 8). IFNa 1 represents interferon a–treated cells. As-
terisk marks unspecific protein recognized by anti–PML anti-
body. It indicates equal protein load. Arrowheads mark most
abundant Sp100 and PML signals. Higher molecular mass
polypeptides represent alternative splicing or posttranscrip-
tional modification (by SUMO-1 or phosphorylation) of pro-
teins. It is clearly seen that NT2 cells do not express Sp100 in
normal and IFNa–upregulated conditions (lanes 1 and 2), whereas in HEp-2 cells IFNa upregulation results in a dramatic increase of
Sp100 signal (lanes 3 and 4). Endogenous as well as IFNa–upregulated PML are present in both cell lines (lanes 5–8). 
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Figure 2. PML is responsible for the proper localization of all other ND10-associated proteins. Confocal micrographs of immunola-
beled proteins are presented with the respective colors in the upper corners of the image. Cell type and overexpressed protein are indi-
cated at the lower part of the image. (A) MPEF cells labeled for Sp100 and PML; the major ND10-associated proteins are present in
mouse ND10. (B) MPEF cells double labeled for NDP55; mouse ND10 contain NDP55. C. MPEF cells double labeled for SUMO-1
and PML; mouse ND10 contain SUMO-1–modified proteins. D–H represent the same fields as in pictures above emphasizing the high-
est concentration of the corresponding proteins in ND10. (G) PML2/2 MPEF cells labeled for Sp100 showing this protein only is dis-
persed throughout the nucleus in the absence of PML. (H) PML2/2 MPEF cells labeled for NDP55; NDP55 is dispersed in the nucleus.
(I) PML2/2 MPEF cells labeled for SUMO-1; SUMO-1 is dispersed in the nucleus. (J) PML-transfected (left upper and lower cells)
PML2/2 MPEF labeled for Sp100 and PML showing that Sp100 is recruited to ND10-like sites. (K) PML transfected (right, upper and
lower cells) PML2/2 MPEF labeled for NDP55 and PML; NDP55 is recruited to ND10-like sites. (L) PML transfected PML2/2
MPEF (left upper and lower cells) labeled for SUMO-1 and PML; SUMO-1 is recruited to ND10-like sites. Note exclusive nuclear lo-
calization of SUMO-1 even when PML is accumulated in the cytoplasm. 
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panel of antibodies that reacted with several mouse ND10-
associated proteins. We had identified a rabbit antibody
that reacted with human and mouse PML and labeled
ND10 in mouse fibroblasts (Fig. 2, A–C). This antibody
was used to identify antibodies that were specific for mouse
proteins located in ND10. Screening several Sp100-positive
human autoantibodies, we identified one that interacts
with mouse Sp100 (Fig. 2, A and D). Antibody specificity
was confirmed by Western blotting using recombinant
Sp100. In addition, the anti-NDP55 mAb labeled ND10
(Fig. 2, B and E). Also, SUMO-1, which can modify both
PML and Sp100, was detected in mouse ND10 (Fig. 2, C
and F). To show that Sp100, NDP55, and SUMO-1 are
concentrated in ND10, they are presented as separate
green images below the merged one in the upper row. This
panel of four antibodies recognized mouse ND10 and was
used to probe for the presence of ND10 in PML
 
2
 
/
 
2
 
MPEF.
When PML
 
2
 
/
 
2
 
 MPEF were tested for the distribution
of the different ND10-associated proteins, neither Sp100,
NDP55, nor SUMO-1 was seen in typical ND10. Instead,
these proteins appeared throughout the nucleus without
any ND10 accumulations (Fig. 2, compare D–F with G–I).
The distribution pattern of three ND10-associated pro-
teins, in the absence of PML, suggested PML as a likely
candidate for establishing ND10 integrity. To test this pos-
sibility, we expressed PML in the PML
 
2
 
/
 
2
 
 MPEF cells
by transient transfection and probed for the location of
Sp100, NDP55, and SUMO-1. At low expression levels,
PML appeared in domains with the frequency and distri-
bution of ND10 in wild-type cells (Fig. 2, J–L). Upon accu-
mulation of PML, larger aggregates with a lower fre-
quency appeared (Fig. 2 J, compare lower left and upper
left cells) and sometimes cytoplasmic accumulations (Fig.
2 L, lower cell) were seen. All tested mouse ND10 pro-
teins were segregated into PML-positive structures. These
observations established that PML is essential for the as-
sembly of ND10 and for the segregation and accumulation
of ND10-associated proteins.
 
Daxx Is a New Component of ND10 and Interacts
with PML
 
It has been shown before that PML cannot interact with
Sp100 directly (Sternsdorf et al., 1997). However, it can
recruit Sp100 into ND10 upon transient expression in
PML
 
2
 
/
 
2
 
 MPEF cells. We concluded that some adapter
proteins must mediate this interaction and searched for
new proteins that were part of ND10 and interacted with
PML. In previous studies, we had cloned human Daxx
through its ability to bind to the steroidogenic factor-
1–like binding site in the human steroidogenic acute regu-
latory protein gene promoter DNA sequence (Kiriaki-
dou et al., 1997). Rabbit antibodies produced against this
protein showed an ND10-like nuclear distribution. When
compared with PML, Daxx colocalized perfectly in ND10
(Fig. 3, A–C). Since Daxx interacts with the death domain
of Fas (Yang et al., 1997) and, therefore, was anticipated
to be a cytoplasmic protein, we confirmed the ND10 loca-
tion of Daxx with two other independently generated anti-
bodies to ensure that the antigen detected in ND10 was
truly identical to Daxx. Both a commercial rabbit antibody
and a mouse antibody produced against a recombinant
hDaxx fragment reacted with the same structure as did
PML antibodies. Specificity of Daxx antibodies were con-
firmed by Western blot analysis of in vitro translated
hDaxx (not shown). These experiments strongly argued
against the possibility that antibodies identified a spurious
localization.
In addition to Fas, Daxx was shown to interact with
CENP-C and to be located at centromeres in a cell cycle–
dependent fashion (Pluta et al., 1998). When we used hu-
man autoantibodies against centromeric proteins together
with Daxx antibodies in wild-type mouse fibroblasts, we
observed that a few sites did appear to colocalize. How-
ever, in most cases Daxx was situated beside centromeres
or was not apparent at centromeres (Fig. 3 D). We con-
cluded that Daxx is at its highest concentration in ND10
and is, therefore, a novel ND10-associated protein.
To investigate the possibility that the localization of
Daxx reflects an interaction between Daxx and another
ND10-associated protein, we employed the yeast two-
hybrid assay. We determined whether Daxx could interact
with Sp100 and/or PML fused to GAL4DB. Daxx was
fused to VP16 and the VP16-producing plasmid was used
as a negative control. To quantitate the strength of interac-
tion, we used the liquid 
 
b
 
-galactosidase assay. Using this
assay, we did not observe any evidence of interaction be-
tween Daxx and Sp100. In contrast, Daxx strongly inter-
acted with PML (Table I).
To assess the specificity of this interaction, we mapped
the region of Daxx that is required for interaction with
PML (see Table I for details). The PML coil-coiled region
deletion mutant can still interact with Daxx, although it
can also interact with Vp16 alone (see also Ahn et al.,
1998). Unexpectedly, two of the Daxx NH
 
2
 
-terminal dele-
tion mutants (amino acids 488–740 and 625–740) inter-
acted with PML approximately threefold more strongly
than the full-length molecule. The NH
 
2
 
-terminal region of
Daxx can lower the strength of its interaction with PML,
probably as a result of protein folding. In contrast, the
COOH-terminal deletion mutant (amino acids 1–625) and
the smallest COOH-terminal construct (amino acids 661–
740) failed to interact at all. Another Daxx deletion mu-
tant (amino acids 433–740) showed an 
 
z
 
20-fold weaker in-
teraction than the Daxx 488–740 amino acid mutant. The
weaker signal might reflect the exposure of the acidic
amino acid–rich region between amino acids 434 and 485,
diminishing the interaction. Thus, the PML interaction do-
main, as defined by the yeast two-hybrid assay, lies be-
tween amino acids 625 and 740, and amino acids 625–661
are essential for this interaction. Together, these data
demonstrate that Daxx interacts with PML and suggests
that the spatial colocalization of PML and Daxx in ND10
reflects an interaction between these two proteins.
 
Daxx Location Is Mediated by PML
 
The results of the yeast two-hybrid assay indicated that
Daxx and PML interacted, and the colocalization of the
two proteins in ND10 was consistent with physiological as-
sociation. To test whether various deletions in Daxx would
affect Daxx localization in the context of mammalian cells,
we fused the mutants with GFP-NLS. In agreement with 
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Figure 3. The new ND10-associated protein Daxx and its localization upon ND10 destruction and reconstitution. Confocal micrographs
of immunolabeled proteins are presented with the respective colors in the upper corners of the image. Cell type and overexpressed pro-
teins are indicated in the lower part of the image. (A–C) MPEF cells labeled for Daxx (A), PML (B), and both proteins (C) shown to
colocalize at ND10. (D) PML2/2 MPEF cells double labeled for centromeres and PML; some centromeres are associated with Daxx-
positive sites, but mostly Daxx is not present in the same space as centromeres. (E–G) PML2/2 MPEF cells double labeled for Daxx
(E) and DNA (F), and together (G) show Daxx located at the condensed chromatin in the absence of PML. (H–J) PML2/2 MPEF
cells transfected to express PML (upper cell) and labeled for PML (H), Daxx (I), and both proteins (J); Daxx is located in PML-positive
sites and contrary to the untransfected cells, very little is in the nucleoplasm and is unrecognizable at sites that may resemble condensed
chromatin. (K–N) PML2/2 MPEF cells fused to HF and stained for DNA (K) identifying the lower and left upper cell as of mouse or-
igin by their DNA staining of condensed chromatin, and the right upper cell as human. Staining for PML is shown in L and for Daxx in
M. In the merged image (N), the left upper mouse cell is shown to contain human PML and is, therefore, fused to HF. In the fused
mouse cell, Daxx is present not only at condensed chromatin as in the lower mouse cell, but also in ND10-like domains. 
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indirect immunofluorescence results, the GFP-Daxx fu-
sion protein was found to accumulate efficiently at PML-
positive sites (Fig. 4, A–C). In contrast, the COOH-termi-
nal deletion mutant (amino acids 1–595), which lacked the
PML-interacting region, was diffusely present throughout
the nucleus and was not accumulated at PML-positive
sites (Fig. 4, D–F). The results from the yeast two-hybrid
interaction were also confirmed by the finding that the
Daxx COOH-terminal region (amino acids 624–740) alone
was sufficient to localize GFP to ND10 (Fig. 4, G–I).
These data suggest that Daxx interaction with PML is nec-
essary for ND10 localization.
If Daxx is accumulated in ND10 through interaction
with PML, one would predict a different Daxx distribution
in cells without PML. In normal mouse fibroblasts, Daxx
colocalized specifically with PML in ND10 (Fig. 3, A–G).
However, in the absence of PML (mouse PML
 
2
 
/
 
2
 
 fibro-
blasts), we found the localization of Daxx to be quite dif-
ferent. Daxx was localized in patches which, when coun-
terstained for DNA, proved to be condensed chromatin
(Fig. 3, E–G). Therefore, in the absence of ND10, con-
densed chromatin is an alternative nuclear compartment
of Daxx accumulation.
To investigate the relationship between PML and Daxx
further, we tested whether PML could recruit endogenous
Daxx into ND10 when transiently expressed in PML
 
2
 
/
 
2
 
MPEF cells. As shown in Fig. 3, H–J, the untransfected
PML
 
2
 
/2 MPEF cells exhibited the patchy Daxx distribu-
tion characteristic of its condensed chromatin location. In
PML-transfected cells (Fig. 3, H–J, upper cell), Daxx was
not seen at condensed chromatin but, instead, now colo-
calized almost exclusively with PML. These PML-induced
structures were found to also contain the other ND10-
associated proteins (Fig. 2, J–L) and were, therefore, con-
sidered to be ND10.
To test if PML could restore Daxx accumulation at
ND10 without the strong overexpression induced by tran-
sient transfection, we performed a cell fusion experiment
where PML2/2 MPEF cells were fused with human fi-
broblasts as a source of PML. Species specificity of the
cells was determined by DNA distribution, which showed
strongly condensed chromatin for mouse cells (Fig. 3 K,
compare left and lower cells with the one in the upper
right). In unfused mouse cells (Fig. 3, K–N, lower cell),
Daxx appeared at its highest concentration only in con-
densed chromatin. But in another mouse cell (upper left
cell), which became positive for human PML as a result of
fusion with HF (upper right cell), Daxx started to appear
in additional domains that colocalized with PML. In this
experiment we could not distinguish between human and
mouse Daxx. However, the finding that mDaxx, after
hPML overexpression in PML2/2 MPEF cells was re-
cruited to ND10 (Fig. 3 J), made it likely that in the fusion
experiment mDaxx could be accumulated into PML-posi-
tive structures. Therefore, we concluded that physiological
quantities of PML can induce ND10 formation in nuclei
that normally do not have them.
SUMO-1 Modification of PML Is Essential for Daxx 
Recruitment to ND10
PML has been shown to be modified by SUMO-1 at least
at three sites. The SUMO-1 modification seemed neces-
sary for the deposition of PML at ND10 (Kamitani et al.,
1998a; Muller et al., 1998). Therefore, we were interested
in determining whether this modification affected inter-
action with Daxx. Double labeling of HEp-2 cells for
SUMO-1 and overexpressed PML showed that PML in
the nucleus colocalized with SUMO-1 in large aggregates,
and that the cytoplasmic PML aggregates did not stain for
SUMO-1. This suggested that only nuclear PML was
modified by SUMO-1 (Fig. 5, A and E, compare yellow
nuclear domains resulting from the PML/SUMO-1 colo-
calization and red staining of cytoplasmic PML). We
tested whether elimination of SUMO-1 modification sites
in PML influenced SUMO-1 aggregation in PML-positive
sites. SUMO-1 modification sites have been identified pre-
viously at lysines 65, 160, and 490 (Kamitani et al., 1998a).
We transfected HEp-2 cells with RGS–His-tagged PML
mutants containing successively decreasing numbers of
Table I. PML–Daxx and Sp100–Daxx Interaction in the Yeast Two-Hybrid System
As the activation hybrid, we used Vp16 fused with indicated domains of Daxx. DNA-binding hybrids contained Gal-4 DBD fused with PML wild-type, PMLDcoil (amino acids
214–329 deleted), or Sp100 wild-type. b-Galactosidase units were determined as described in Materials and Methods. Different domains of Daxx are shown as open bars on the
schematic drawing of wild-type protein with the corresponding amino acid indicated.Ishov et al. Interaction of PML and Daxx in the Formation of ND10 229
SUMO-1–modified lysines and analyzed the localization
of these overexpressed PML mutants and endogenous
SUMO-1. We observed that a decrease of SUMO-1 accu-
mulation in PML domains paralleled the number of mu-
tated lysines. Shown in Fig. 5, B and F, are cells trans-
fected with the RGS–His-tagged mutant PMLDSUMO, in
which all three lysine residues are substituted with argi-
nine. Upon high PMLDSUMO accumulation, similar en-
larged and later distorted ND10 appear as seen for the
wild-type PML overexpression, except that these accumu-
lations did not label with SUMO-1 antibodies like the
wild-type PML accumulations (Fig. 5 A, compare upper
right cell with lower right cell). Contrary to published re-
ports, all PML mutants were accumulated at ND10 (rec-
ognized by the location of endogenous SUMO-1) at low
level of expression (Fig. 5, B and F, upper two cells are
transfected, lower right is not transfected). This PMLD-
SUMO accumulation indicates that either SUMO-1 modi-
fication is not necessary for ND10 targeting of PML and/
or is due to potential dimer formation between PMLD-
SUMO and wild-type PML, where the wild-type PML
would serve as an ND10 targeting vehicle. We concluded
that SUMO-1–modified PML appears only in the nucleus,
and confirmed in situ that PMLDSUMO is not SUMO-
1–modified.
We tested whether endogenous Daxx recruitment into
ND10 was influenced by the level of PML SUMO-1 mod-
ification. HEp-2 cells were transfected with PML and
PMLDSUMO expression plasmids and tested for the lo-
cation of endogenous Daxx. We found that Daxx is accu-
mulated in domains formed by wild-type PML but not in
those formed by PMLDSUMO (Fig. 5, compare lower
cell in C and G with lower left cell in D and H; the cell in
the upper left of D and H is not transfected). These data
demonstrate that Daxx accumulation at ND10, and po-
tentially PML-Daxx interaction, depends on SUMO-1
Figure 4. Localization of GFP-fused wild-type Daxx and Daxx mutants upon transfection. Confocal micrographs presenting HEp-2
cells transiently transfected by plasmids expressing Daxx and Daxx mutants fused with GFP and stained by PML (A, D, and G) and
GFP (B, E, and H). Merged images are presented in C, F, and I. Overexpressed proteins are indicated in the lower part of the image.
(A–C) HEp-2 cells 16 h after transfection with wild-type Daxx fused to GFP-NLS; transiently expressed Daxx accumulates in PML-pos-
itive sites. (D–F) HEp-2 cells 16 h after transfection with Daxx 1-595 fused to GFP-NLS; this COOH-terminal deletion mutant does not
accumulate in PML-positive sites. (G-I) HEp-2 cells 16 h after transfection with Daxx 624-740 fused to GFP-NLS; the transiently ex-
pressed Daxx COOH-terminal fragment accumulates in PML-positive sites but also floods the nucleoplasm.The Journal of Cell Biology, Volume 147, 1999 230
modification of PML (Fig. 5, compare A and B with C
and D). If PMLDSUMO does not recruit endogenous
Daxx into domains, both proteins should not colocalize
upon overexpression. When we cotransfected Daxx and
PML into HEp-2 cells, we found that the two proteins
colocalized in the nucleus (Fig. 5, I and J). However,
PMLDSUMO and Daxx formed separated aggregates
upon overexpression (Fig. 5, K and L). Taken together,
Figure 5. SUMO-1 modification of PML is important for Daxx localization. Confocal micrographs of immunolabeled proteins are pre-
sented with the respective colors in the upper corners of the image. Cell type and overexpressed proteins are indicated in the lower part
of the image. (A and E) PML-transfected HEp-2 cells double labeled for SUMO-1 and PML (A) or SUMO-1 only (E). SUMO-1 and
PML colocalized only in the nucleus. (B and F) HEp-2 cells transfected to express the triple SUMO-1 site deletion PML mutant
(PMLDSUMO) double labeled for His-tagged PMLDSUMO and SUMO-1 (B) or SUMO-1 only (F); PMLDSUMO is accumulating in
ND10-like structures in the upper two transfected cells; endogenous SUMO-1 indicating the location of ND10. There is no SUMO-1 in
large nuclear PMLDSUMO aggregates of the lower right cell as compared with the large aggregates of wild-type PML in A. The lower
left cell is not transfected. (C and G) PML-transfected HEp-2 cells double labeled for Daxx and PML (C) or Daxx only (G); Daxx is ac-
cumulated in PML-positive sites. (D and H) HEp-2 cells transfected by His-tagged PMLDSUMO and double labeled for Daxx and
PMLDSUMO (D) or Daxx only (H); there is no Daxx in the mutant PML accumulations as compared with the wild-type PML transfec-
tion in C. The upper left cell is not transfected. (I and J) HEp-2 cells double transfected to express PML and Daxx and double labeled for
Daxx and PML (I) or Daxx only (J); Daxx and PML colocalized, but in the nucleus only. (K and L) Daxx and PMLDSUMO double-
transfected HEp-2 cells double labeled for Daxx and His-tagged PMLDSUMO (K) or Daxx only (L); Daxx and PMLDSUMO are de-
posited in different spaces.Ishov et al. Interaction of PML and Daxx in the Formation of ND10 231
these results show that the SUMO-1 modification of
PML determines the ability of PML to segregate Daxx
into ND10.
Discussion
The nucleus has been increasingly segmented into differ-
ent domains that relate to the traditional nuclear functions
of replication and transcription. These domains are de-
fined by specific chromosomal territories (Lichter et al.,
1988), replication sites (Wei et al., 1998), transcription
sites (Jackson et al., 1993), or domains that contain excess
splicing components (Spector et al., 1991). Like the nucle-
olus, coiled bodies have been suggested to reflect high
rates of transcription because of the localization of certain
genes at these sites (Gao et al., 1997; Smith et al., 1995).
Nuclear domains such as ND10 and Gemini have gained
attention through their connection to specific diseases
(Szostecki et al., 1990; Maul et al., 1993; Dyck et al., 1994;
Liu and Dreyfuss, 1996; Liu et al., 1997) or viral infections
(Maul et al., 1993, 1996; Maul and Everett, 1994; Ishov and
Maul, 1996; Ishov et al., 1997). For ND10, a function in
transcription also has been postulated (LaMorte et al.,
1998). The role ND10 plays as a structure remains unclear,
although we have suggested that these domains function
as nuclear depots for a number of proteins (Maul, 1998).
Such a model dissociates the function of the respective
ND10-associated proteins from their location at ND10. It
also suggests that physiologically relevant interactions of
these proteins with other proteins might occur at different
locations. Recruitment of proteins from nucleoplasm to
ND10, leading to the changes in the intranuclear protein
balance, may affect cellular functions.
Modification of ND10 in a number of pathological pro-
cesses strongly suggests that investigating the ND10 as-
sembly mechanism is an essential step towards under-
standing the function of this nuclear structure. Using cells
that lack either Sp100 or the newly described ND10-asso-
ciated protein BML, we demonstrated that neither the lack
of Sp100 nor the absence of BLM affected the structure of
ND10. In contrast, cells lacking PML exhibited dispersion
of all ND10-associated proteins. ND10 could be recon-
structed by the introduction of PML into PML2/2 cells
either by transfection or, at more physiological concentra-
tions of PML, through the fusion with PML-containing
cells. This reconstruction includes the recruitment of all
ND10 proteins, including Sp100, which does not interact
with PML, suggesting the presence of mediator proteins.
Our observation establishes that PML is the essential pro-
tein for ND10 assembly under physiological conditions.
The destruction of ND10 induced by the herpes virus
immediate early gene products (IE1 of HCMV and ICP0
of HSV; Everett and Maul, 1994; Kelly et al., 1995; Ishov
et al., 1997; Ahn et al., 1998; Everett et al., 1998) supports
the notion that PML plays a central part in the mainte-
nance of ND10. Particularly the direct interaction of IE1
with PML (Ahn et al., 1998) may deprive ND10 of PML
and so lead to their destruction. Consistent with this effect,
constitutive expression of IE1 in astrocytoma cells and hu-
man fibroblasts also results in the loss of detectable ND10
(Ishov, A.M., unpublished observation).
The formation of ND10 has been found to accompany
APL remission in promyelocytes (Dyck et al., 1995). After
retinoic acid treatment of APL-derived NB4 cells, the
dominant negative PML–retinoic acid receptor a (PML-
RARa) fusion protein is selectively hydrolyzed through
the proteosome pathway, releasing wild-type PML (Mul-
ler et al., 1998). This, in turn, might be the reason for
ND10 formation in RA-treated NB4 cells, which normally
have only dispersed ND10-associated proteins. Therefore,
the recovery of ND10 may be a consequence of PML
availability, which leads to the segregation of other ND10
proteins.
The central role of PML in ND10 formation suggests
the presence of proteins that are accumulated at ND10
through interaction with PML. We found that the recently
cloned DNA-binding protein Daxx (Kiriakidou et al.,
1997; Yang et al., 1997) was highly concentrated in ND10.
Moreover, we found that Daxx interacted with PML in the
yeast two-hybrid assay, mapped the interaction domain of
Daxx, and demonstrated that Daxx localization at ND10
depended on the presence of a PML interaction domain as
well as SUMO-1 modification of PML. The discrepancy
between previously reported Daxx interactions with Fas
(Yang et al., 1997), CENP-C (Pluta et al., 1998), and ND10
localization of this protein suggests that Daxx does not ac-
cumulate together with all interaction partners, but is pref-
erentially accumulated at ND10.
In the absence of PML in PML2/2 MPEF cells, ND10
are destroyed. Therefore, ND10-associated proteins are
expected to be found at their alternative binding locations.
Most of these proteins were dispersed throughout the nu-
cleus and, thus, were not amenable to microscopic analy-
sis. Only Daxx was detected at higher concentrations in
the areas of condensed chromatin. Daxx was removed
from these chromatin regions through the introduction of
PML by transient transfection concomitant with the for-
mation of ND10. Therefore, these chromatin regions have
a substantial amount of unsaturated Daxx binding sites.
We propose that Daxx acts at sites other than ND10 by in-
teractions with DNA (Kiriakidou et al., 1997) or other
proteins (Yang et al., 1997; Pluta et al., 1998; Hollenbach
et al., 1999) at a variety of cellular locations. Whether the
balance of Daxx between ND10 and condensed chromatin
can be modified under physiological conditions is not yet
conclusively established; however, such a balance may
constitute a potential control mechanism.
A key finding of our study was that the Daxx accumula-
tion in ND10 is dependent on SUMO-1 modification of
PML. In the yeast two-hybrid system, SMT3, the yeast ho-
mologue of SUMO-1 (Lapenta et al., 1997), may have fa-
cilitated the PML–Daxx interaction. Moreover, conjuga-
tion of SMT3 to other yeast proteins is facilitated by Ubc9
(Johnson and Blobel, 1997; Schwarz et al., 1998), the yeast
homologue of human Ubc9, which is involved in the
SUMO-1 modification of PML (Duprez et al., 1999). Fail-
ure to coimmunoprecipitate in vitro translated Daxx with
recombinant PML (not shown) is consistent with the idea
that SUMO-1 modification of PML mediates this interac-
tion.
The SUMO-1 modification level of PML might be a de-
terminant of the amount of Daxx recruited and the avidity
with which Daxx is retained at ND10. Therefore, the regu-
lated posttranslational modification of PML may balanceThe Journal of Cell Biology, Volume 147, 1999 232
the amount of Daxx available in the nucleus. Contrary to
previous reports (Kamitani et al., 1998a; Muller et al.,
1998), we found that SUMO-1 modification may not be es-
sential for the deposition of PML at ND10, but rather re-
sults in the Daxx accumulation at this domain. The central
role of PML in ND10 formation suggests the presence of a
protein network where some adapter proteins can mediate
recruitment of non-PML–interacting proteins to ND10.
Daxx may act as such an adapter and recruit other ND10-
associated proteins that do not bind directly to PML (Ne-
gorev, D., unpublished results).
An emergent hierarchical model for ND10 formation is
presented schematically in Fig. 6. The appearance of
ND10 after mitosis must result from a nucleation event
possibly through homo- or heteromultimerization of PML.
This event may take place at specific nuclear deposition
sites, as postulated earlier (Maul, 1998). Transcriptional
activation, for instance by interferon, can upregulate PML
expression (Lavau et al., 1995), nucleating additional ag-
gregation sites. SUMO-1 modification-demodification of
PML (third level) may lead to a reversible accumulation of
Daxx to ND10 (fourth level), increasing or decreasing the
availability of this protein for alternative binding partners
(DNA, CENP-C, Fas, Pax3, DNA methyltransferase), and
thus regulate corresponding functions. The complexity
and plasticity of such a supramolecular regulatory mecha-
nism are evident and envisioned structurally as a network
of interacting proteins with PML at its core.
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